Interim report January – September 2020
Curasight A/S (“Curasight” or “the Company”) hereby publishes the interim report for the period January 1 – September 30, 2020. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Curasight’s CEO Ulrich Krasilnikoff comments: “The Company’s recent financial injection paired up with our pioneering technology puts Curasight in an excellent position to realize our goal of being at the forefront of a paradigm shift in treating and diagnosing cancer. Together with the strong and broad pipeline of studies using